Bell Katharina, Wilding Corina, Funke Sebastian, Perumal Natarajan, Beck Sabine, Wolters Dominik, Holz-Müller Jana, Pfeiffer Norbert, Grus Franz H
Experimental Ophthalmology, Department of Ophthalmology, Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
J Neurochem. 2016 Oct;139(2):256-269. doi: 10.1111/jnc.13765. Epub 2016 Sep 16.
Glaucoma, a neurodegenerative disease, is characterized by a progressive loss of retinal ganglion cells (rgc). Up- and down-regulated autoantibody immunoreactivities in glaucoma patients have been demonstrated. Previous studies showed protective effects of down-regulated antibodies [gamma (γ)-synuclein and glial fibrillary acidic protein [GFAP]) on neuroretinal cells. The aim of this study was to test these protective antibody effects on rgc in an organ culture model and to get a better understanding of cell-cell interactions of the retina in the context of the protective effect. We used an adolescent retinal organ culture (pig) with an incubation time of up to 4 days. Retinal explants were incubated with different antibodies for 24 h (anti-GFAP, anti-γ-synuclein and anti-myoglobin antibody as a control). Brn3a and TUNEL staining were performed. We also conducted glutamine synthetase staining and quantification of the retinal explants. Mass spectrometry analyses were performed as well as protein analyses via microarray. We detected a continuous decrease of rgc/mm in the retinal explants throughout the 4 days of incubation with increased TUNEL rgc staining. Immunohistochemical analyses showed a protective effect of anti-γ-synuclein (increased rgc/mm of 41%) and anti-GFAP antibodies (increased rgc/mm of 37%). Mass spectrometric, microarray and immunohistochemical analyses demonstrated Müller cell involvement and decreased endoplasmic reticulum stress response in the antibody-treated retinae. We could detect that the tested antibodies have a protective effect on rgc which seems to be the result of reduced stress levels in the retina as well as a shift of glutamine synthetase localization in the endfeet of the Müller cells towards the inner retinal layer. Loss of retinal ganglion cells (rgc) in glaucoma leads to blindness. Several antibodies are down-regulated in glaucoma patients. Our aim was to test if these antibodies have a protective effect of rgc in a retinal organ culture. This could be shown with an increase of rgc numbers. This effect results through reduced stress levels and the shift of glutamine synthetase localization.
青光眼是一种神经退行性疾病,其特征是视网膜神经节细胞(RGC)逐渐丧失。青光眼患者体内自身抗体免疫反应性存在上调和下调现象。先前的研究表明,下调的抗体(γ-突触核蛋白和胶质纤维酸性蛋白[GFAP])对神经视网膜细胞具有保护作用。本研究的目的是在器官培养模型中测试这些保护性抗体对RGC的作用,并在保护作用的背景下更好地理解视网膜的细胞间相互作用。我们使用了青春期视网膜器官培养物(猪),培养时间长达4天。将视网膜外植体与不同抗体孵育24小时(抗GFAP、抗γ-突触核蛋白和抗肌红蛋白抗体作为对照)。进行了Brn3a和TUNEL染色。我们还对视网膜外植体进行了谷氨酰胺合成酶染色和定量分析。进行了质谱分析以及通过微阵列进行的蛋白质分析。在整个4天的孵育过程中,我们检测到视网膜外植体中RGC/mm持续减少,TUNEL RGC染色增加。免疫组织化学分析显示抗γ-突触核蛋白(RGC/mm增加41%)和抗GFAP抗体(RGC/mm增加37%)具有保护作用。质谱、微阵列和免疫组织化学分析表明,抗体处理的视网膜中Müller细胞参与其中,内质网应激反应降低。我们可以检测到,所测试的抗体对RGC具有保护作用,这似乎是视网膜应激水平降低以及谷氨酰胺合成酶在Müller细胞终足中的定位向内视网膜层转移的结果。青光眼患者视网膜神经节细胞(RGC)的丧失会导致失明。青光眼患者体内几种抗体下调。我们的目的是测试这些抗体在视网膜器官培养中是否对RGC具有保护作用。这可以通过RGC数量的增加来证明。这种作用是通过降低应激水平和谷氨酰胺合成酶定位的转移实现的。